금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
EUR/USD reacts to data: Fed rate hike expectations fall
EUR/USD stood at 1.1537 on Friday, with markets continuing to digest incoming economic data. Soft US...
New highs for stocks as confidence returns
Soft PPI and CPI readings in the US, on top of renewed confidence in AI trades, have helped the S&P ...
Norwegian Krone: Weaker after Norges Bank holds rates – Danske Bank
Danske Research Team notes that Norges Bank left its policy rate at 4.25% and kept a tightening bias...
Singapore Dollar: AI exports support SGD against US Dollar – Commerzbank
Commerzbank’s Moses Lim and Dr. Henry Hao note that Singapore’s June non-oil domestic exports (NODX) growth moderated to 20.7% year-on-year but remained strong, with electronics exports surging on AI- ...
What will Tesla say during their next earnings call? – Kalshi
America's Car-Mart facing few options as liquidity pressures mount — report
Gold price rallies amid Gulf war strikes, strong US Dollar
Gold price surges on Tuesday during the North American session, up by more than 1.50% amid continued missile strikes between the US and Iran despite mediators' efforts to end the war. The XAU/USD trad ...
Pembina Pipeline cut at Scotiabank with fewer catalysts seen in H2
Equifax outlines 3Q 2026 revenue of $1.68B-$1.71B as it targets $150M in AI productivity savings through 2028
Genuine Parts outlines 2026 adjusted EPS of $7.50-$8.00 while targeting separation in Q1 2027
VEA Is Crushing SPY This Year, but the Decade-Long Scorecard Tells a Different Story
VEA has quietly outpaced the S&P 500 over the past year, and the gap is widening in 2026, but a longer look at the scoreboard raises a question every U.S.-heavy investor needs to sit with before addin ...
Getting International Exposure in ETFs Isn't Always an Easy Choice. Is SPGM or IEFA the Better Buy for 2026?
SPGM's total-world approach delivered 23.1% one-year gains versus IEFA's 19.9%, though the iShares fund offers higher dividend income and lower costs.
Which Healthcare ETF Is the Better Buy: iShares' Global IXJ or First Trust's Biotech FBT?
One fund owns the giants of global healthcare, while the other bets on 30 smaller biotech companies.
Wintrust Financial cut to Neutral at Brean Capital on valuation, shares down
AbbVie Stock Zigs When The Market Zags
This pharma giant is grabbing headlines, but its real value for your portfolio lies in how it moves on the market's worst days.